1. Lafont, Elodie, Draber, Peter, Rieser, Eva, Linkermann, Andreas, Walczak, Henning. 2018. TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation. In Nature cell biology, 20, 1389-1399. doi:10.1038/s41556-018-0229-6. https://pubmed.ncbi.nlm.nih.gov/30420664/
2. Zhang, Conggang, Shang, Guijun, Gui, Xiang, Bai, Xiao-Chen, Chen, Zhijian J. 2019. Structural basis of STING binding with and phosphorylation by TBK1. In Nature, 567, 394-398. doi:10.1038/s41586-019-1000-2. https://pubmed.ncbi.nlm.nih.gov/30842653/
3. Duan, Qing-Qing, Wang, Han, Su, Wei-Ming, Wang, Yi, Chen, Yong-Ping. 2024. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro. In BMC medicine, 22, 96. doi:10.1186/s12916-024-03314-1. https://pubmed.ncbi.nlm.nih.gov/38443977/
4. Barbie, David A, Tamayo, Pablo, Boehm, Jesse S, Jacks, Tyler, Hahn, William C. 2009. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. In Nature, 462, 108-12. doi:10.1038/nature08460. https://pubmed.ncbi.nlm.nih.gov/19847166/
5. Tanaka, Yasuo, Chen, Zhijian J. 2012. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. In Science signaling, 5, ra20. doi:10.1126/scisignal.2002521. https://pubmed.ncbi.nlm.nih.gov/22394562/
6. Ghosh, Monisankar, Saha, Suchandrima, Bettke, Julie, van der Velden, Adrianus W M, Martinez, Luis A. 2021. Mutant p53 suppresses innate immune signaling to promote tumorigenesis. In Cancer cell, 39, 494-508.e5. doi:10.1016/j.ccell.2021.01.003. https://pubmed.ncbi.nlm.nih.gov/33545063/
7. Ritch, Robert, Darbro, Ben, Menon, Geeta, Lotery, Andrew J, Fingert, John H. . TBK1 gene duplication and normal-tension glaucoma. In JAMA ophthalmology, 132, 544-8. doi:10.1001/jamaophthalmol.2014.104. https://pubmed.ncbi.nlm.nih.gov/24699864/
智鼠故事 
